Health Condition 1: null- ASA I & II undergoing surgery under general anaesthesia
Conditions
Interventions
Intervention1: dexmedtomidine: alpha 2 agonist
dose: 0.25microgram /kg injected once over 5 secs intravenously
Control Intervention1: Lignoacine, Dexmedtomidine , Normal saline: ligocaine: local anaes
Sponsors
nil
Eligibility
Inclusion criteria
Inclusion criteria: Written informed consent. Patients of either sex. Aged between 17 -70 years Belonging to ASA GRADE 1 and 2( Based on the physical status,the patients are classified into categories by American Society of Anaesthesiologists) Requiring standard General Anaesthesia (G.A)
Exclusion criteria
Exclusion criteria: Concomitant analgesic or sedative medication, patients requiring rapid sequence induction, anticipated difficulty venous access, difficulty in communication Known sensitivity to lignocaine or dexmedetomidine Conditions where use of lignocaine and dexmedetomidine may be harmful Presence of infection on the dorsum of hand
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence and severity of pain due to propofol injection. Effect of lignocaine, dexmedetomidine and placebo prtreatment in attenuating this pain.Timepoint: AT the time of induction of anesthesia. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the recall of pain in patients after the surgery.Timepoint: In the recovery room after the surgery | — |
Countries
India
Contacts
Public ContactSnigdha
Indira Gandhi Institute of Medical Sciences,Patna
Outcome results
None listed